SIGN UPLog In

General

Financials

People

Activity

Recent News
SeaBeLife
SeaBeLife
Company

Last deal

$1.6M
Local Amount - EUR 1.5M

Amount

Grant

Stage

22.04.2024

Date

3

all rounds

$7.28M

Total amount

date founded

Financing round

General

About Company
SeaBeLife is a biotech company developing drug candidates to block regulated necrosis, with a focus on acute and orphan diseases.

Industry

Sector :

Subsector :

Keywords :

Also Known As

SeaBeLife Biotech

founded date

01.01.2019

Number of employees

1-10

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

SeaBeLife develops and tests original and patented molecules to inhibit regulated necrosis, which is a pathophysiological factor in many severe diseases. The company's lead molecule is currently under preclinical development to treat acute kidney injury and acute liver failure. SeaBeLife has also identified molecules in their pipeline with proof of concept in neurodegenerative diseases and AMD.
Contacts

location

Roscoff, France

Contact Email

Phone number

Website URL

https://www.seabelife.com/

Social url

Legal Names

Legal name

SeaBeLife SAS
Similar Companies
1000
Oisin Biotechnologies
Oisin BiotechnologiesOisin Biotechnologies is a drug development company that uses senolytic technology to combat age-related diseases.
Oisin Biotechnologies

Oisin Biotechnologies

Oisin Biotechnologies is a drug development company that uses senolytic technology to combat age-related diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Seattle, WA, USA

total rounds

5

total raised

$22.12M
Cyxone
CyxoneCyxone is a biotech company that develops drugs to improve the quality of life for people with severe autoimmune diseases.
Cyxone

Cyxone

Cyxone is a biotech company that develops drugs to improve the quality of life for people with severe autoimmune diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Malmö, Sweden
F2G
F2GF2G develops drugs to treat life-threatening fungal diseases.
F2G

F2G

F2G develops drugs to treat life-threatening fungal diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Manchester, UK

total rounds

12

total raised

$283.32M
Virobay
VirobayVirobay develops antiviral drugs for autoimmune diseases, neuropathic pain, liver diseases, and cancer.
Virobay

Virobay

Virobay develops antiviral drugs for autoimmune diseases, neuropathic pain, liver diseases, and cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Biopharma

Location

Menlo Park, CA, USA

total rounds

4

total raised

$23.77M

Financials

Funding Rounds
5
3

Number of Funding Rounds

$7.28M

Money Raised

Their latest funding was raised on 22.04.2024. Their latest investor Bpifrance. Their latest round Grant

Date 
Funding Round 
Investors 
Money Raised 
Lead 
22.04.2024
Grant
1
$1.6M
Local Amount - EUR 1.5M
Bpifrance
Bpifrance
26.09.2023
Seed
5
$1.27M
Local Amount - EUR 1.2M
iX Life
iX Life
14.03.2022
Grant
1
$1.5M
Local Amount - EUR 1.37M
Bpifrance
Bpifrance
Bpifrance

Bpifrance

Bpifrance is a French public investment bank.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Keywords

Financial Services, Banking

Location

Maisons-Alfort, France

count Of Investments

1292

count Of Exists

79
iX Life

iX Life

iX Life is an investment firm.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Finance, Venture Capital

Location

78160 Marly-le-Roi, France

count Of Investments

2
Bpifrance

Bpifrance

Bpifrance is a French public investment bank.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Keywords

Financial Services, Banking

Location

Maisons-Alfort, France

count Of Investments

1292

count Of Exists

79
Co-Investors
Investors
7
2

Number of lead investors

7

Number of investors

Investor 
Lead 
Round 
Partners 
Bpifrance
Bpifrance
Yes
Grant, Seed
—
Business Angels des Grandes Ecoles
Business Angels des Grandes Ecoles
No
Seed
—
BREIZH BREIZH
BREIZH BREIZH
No
Seed
—
Bpifrance

Bpifrance

Bpifrance is a French public investment bank.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Keywords

Financial Services, Banking

Location

Maisons-Alfort, France

count Of Investments

1292

count Of Exists

79
Business Angels des Grandes Ecoles

Business Angels des Grandes Ecoles

BADGE is a top French Business Angels network supporting high-growth startups.

Sector

Software and Computer Services

Subsector

Consumer Digital Services

Keywords

Financial Services, Finance

Location

Paris, France

count Of Investments

20
BREIZH BREIZH

BREIZH BREIZH

BREIZH BREIZH is a business angel association.

Sector

Industrial Support Services

Subsector

Professional Business Support Services

Keywords

Association, Financial Services, Venture Capital

count Of Investments

1

People

Employee Profiles
2
Morgane Rousselot
Morgane Rousselot

Morgane Rousselot

Founder, President, and CEO

Founder, President, and CEO

Claire Delehouze
Claire Delehouze

Claire Delehouze

CTO

CTO

Activity

Recent News
3
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

month